SUMMARY
The objective of this work was to compare the nicotine content and yield of new very low nicotine content cigarettes (VLN™) to the top 100 cigarette brand styles in the United States. Nicotine in tobacco filler and nicotine in smoke were measured. On a dry weight basis, VLN™ cigarettes averaged 0.5 mg of nicotine/g tobacco as compared to 19.4 for the top 100 brand styles in the United States. On a cigarette basis, VLN™ cigarettes contained 0.27 mg of nicotine compared to 12 mg for the top brands. On an ISO smoke yield basis, VLN™ produced 0.03 mg nicotine/cig compared to 0.903 mg nicotine/cig for the leading brands. VLN™ cigarettes contained > 95% less nicotine on a per gram basis of tobacco or per cigarette basis than the top 100 brand styles in the U.S. VLN™ cigarettes yielded > 95% less nicotine in smoke than the top brand styles in the United States. RESUME L'objectif de la présente étude était un comparatif de la teneur et du rendement en nicotine de nouvelles cigarettes à très faible teneur en nicotine (VLN™) par rapport aux styles de cigarettes répertoriés dans le top 100 des marques commercialisées aux Etats-Unis. La nicotine fut mesurée dans la matière de remplissage et dans la fumée. Les cigarettes VLN™ affichèrent une moyenne de 0,5 mg de nicotine par gramme de tabac, exprimée en fonction du poids sec, contre 19,4 mg dans le cas des styles de cigarettes du top 100 des marques commercialisées aux EtatsUnis. Considérant l'ensemble de la cigarette, les cigarettes VLN™ contenaient 0,27 mg de nicotine par cigarette, contre 12 mg pour les marques du classement. Selon la méthode ISO de détermination du rendement de la fumée, les cigarettes VLN™ produisaient 0,03 mg de nicotine par cigarette, contre 0,903 mg de nicotine par cigarette dans le
INTRODUCTION
It is well known that nicotine is the addictive agent in tobacco. In 1994, Drs. BENOWITZ and HENNINGFIELD proposed reducing nicotine levels of all cigarettes over a 10-15-year period (1) . Over the intervening years, literally over a hundred scientific studies were published, evaluating the concept and benefits of very low nicotine cigarettes. In a June 16, 2010 press release, Dr. David Kessler, at the time FDA Commissioner, recommended "The FDA should quickly move to reduce nicotine levels in cigarettes to nonaddictive levels" (2) . Shortly thereafter in a Washington Post newspaper article, Dr. Kessler said that the amount of nicotine in a cigarette should drop from about 10 mg to less than 1 mg (3). In 2017, Dr. Scott Gottlieb, at the time FDA Commissioner, announced a new more comprehensive approach to effective tobacco regulation based on reducing the nicotine levels in cigarettes so that they are minimally or non-addictive (4). As part of the new plan, on March 16, 2018, FDA published an advance notice of proposed rulemaking (ANPRM) announcing an intention to issue a proposed rule that, when finalized and effective, would limit the amount of nicotine in all cigarettes sold in the United States so that they are minimally addictive or nonaddictive (5) . There are no commercially available cigarettes that meet the proposed standard of 0.2-0.7 mg of nicotine per cigarette. In 2011, 22nd Century developed the SPECTRUM® line of research cigarettes in collaboration with the National Institute on Drug Abuse (NIDA), the FDA, the National Cancer Institute and the Centers for Disease Control and Prevention. These cigarettes are made available to researchers through NIDA's Drug Supply Program. The SPEC-TRUM® product line consists of a series of cigarette styles that vary in nicotine content -from very low (~0.4 mg/g tobacco) to relatively high nicotine contents and yields. The nicotine smoke yields range from 0.02 to 1.2 mg nicotine/cig and from 3 to 16 mg of "tar"/cig (6) . SPEC-TRUM® products are available in 24 styles, in both regular and menthol versions, with 8 levels of nicotine in their tobacco. The amount of nicotine in the various styles of SPECTRUM® cigarettes is controlled by blending conventional nicotine content tobacco and tobacco that has been genetically modified 1 and selected to have low levels of nicotine. The lowest nicotine level SPECTRUM® cigarettes contain only very low nicotine tobacco. As nicotine production in tobacco is controlled by multiple genes in the plant, 22nd Century's technology involves blocking or downregulating several genes in the tobacco plant and then selecting for tobacco plant lines that produce the lowest levels of nicotine. SPECTRUM® cigarettes are made with the Company's proprietary Burley tobacco (strain Vector 21-41) at a target nicotine specification level of 0.5 mg/g of tobacco filler (dry weight). The low nicotine level cigarettes are often stated to contain a nominal level of 0.4 mg of nicotine/g of tobacco. These research cigarettes have been produced since 2011 with a target nicotine level of 0.5 mg nicotine/g of dry tobacco filler weight basis accounting for variations in water content. 22nd Century's proprietary low nicotine tobacco was developed in 1998 and has since been used in many cigarettes under different names, including X-22, Xodus, Magic, MAGIC 0, MAGIC 2, Quest®, and the SPEC-TRUM® research cigarettes. Quest® cigarettes were developed and marketed by Vector Tobacco, Inc. under license from 22nd Century from 2002 to 2009. The family of Quest® products included Quest®1 (a cigarette made of conventional tobacco), Quest®2 (a cigarette containing a blend of conventional tobacco and very low nicotine tobacco), and Quest®3 (a cigarette made exclusively with very low nicotine tobacco). Quest cigarettes were marketed to reduce nicotine uptake and nicotine dependency. In 2006, Vector Tobacco filed an Investigational New Drug (IND) Application (number 69,185) with the U.S. FDA for the Quest products with very low nicotine tobacco.
Stepdown reduction in nicotine levels in test cigarettes followed by nicotine replacement therapy (patches) did not affect abstinence at 3 and 6 months when compared to smoking the usual brand followed by nicotine replacement therapy (7) . When Vector stopped the sales of Quest, 22nd Century developed X-22 cigarettes with the intent of obtaining a smoking cessation claim. In 2011, 22nd Century conducted a clinical study with X-22 under IND 103,589. The 4-week study failed to demonstrate cessation efficacy and the clinical development was paused. 22nd Century has developed a version of the SPECTRUM® research cigarette for commercial distribution. This product, trademarked VLN, is exactly the same as the lowest level of nicotine versions of SPECTRUM®. The SPECTRUM® Nicotine Research Cigarettes (NRC) 102 and 103 will be commercially available (after FDA approval) as VLN™ Kings and VLN™ Menthol Kings, respectively. The goal of this research was to evaluate how the nicotine content and yield of VLN™ cigarettes compared to currently marketed cigarettes.
METHODS

Cigarettes
The top 100 cigarette brand styles in the U.S. data (in cartons) for warehouse-delivered products in the convenience store channel made up of both chain and independent stores. The United States convenience store channel universe is made up of 154,000+ stores. MSA collects data from over 60,000 stores. From these 60,000, a sub-set of approximately 30-32,000 convenience stores, both chain and independent, are used to project data to the size of the total convenience store channel. The raw sales data (in cartons) from MSA was categorized at the SKU (stock keeping unit; the bar code on the side of the pack) level. Identical products having different SKUs (because they were purchased with a coupon, or another form of discount, or if they have a slight difference in description) were combined. For testing purposes, the commercial cigarettes were purchased from retail outlets in the Richmond, VA metropolitan area during July 2018. VLN™ cigarettes were provided by 22nd Century Group, Inc. The top 100 brand styles represented more than 80% of all cigarettes sold in the U.S. The brand styles tested are listed in Table 1 . Some of the brand styles were discontinued. The next product on the list was tested. VLN™ King and VLN™ Menthol King are the same cigarettes as the SPECTRUM® NRC102 and NRC103 research cigarettes produced by 22nd Century for NIDA. The only difference between VLN™ King and VLN™ Menthol King is that menthol has been added to the filter of the Menthol King product. All other tobacco, materials, and ingredients are the same in the products. Table 2 shows a comparison of the measured physical properties of VLN™ and SPECTRUM® cigarettes.
Sample analysis
Mainstream smoke collection and analysis of cigarettes were performed using an SM 450 20-port linear smoking machine (Cerulean, Milton Keyes, UK) under ISO conditions of 35 mL volume, 2 s duration with a 60 s puff period. Twenty replicates were analyzed for "tar", nicotine, and carbon monoxide yields. Analysis was conducted following the relevant ISO standards for the analysis of nicotine, water, CO and Nicotine Free Dry Particulate Matter (NFDPM) in mainstream cigarette smoke (8) (9) (10) (11) (12) . The ISO method for the analysis of nicotine in mainstream smoke, ISO 10315, does not cover VLN™ tobacco products because of the low nicotine levels. The work by BROWN et al. has demonstrated that with the addition of lower calibration standards, the method is suitable for the analysis of nicotine in the mainstream smoke of VLN products (13) . At the time of the analyses, all analytical methods were accredited to the ISO 17025 standard (14, 15) . Cigarette filler analysis was conducted from tobacco removed from conditioned cigarettes. Tobacco was composited from 200 cigarettes per brand style. Before analysis, tobacco was ground to a uniform particle size. Nicotine content of the commercial brands was determined by gas chromatography/flame ionization detector (GC-FID) following the CDC method (16) while nicotine content of the VLN products was determined by gas chromatography/ mass spectrometry (GC-MS) following CORESTA Recommend method 87 (17) . Tobacco water content was determined by following the three-hour CDC oven volatiles method (16) .
Determination of "tar", nicotine, and water
Total particulate matter (TPM) from cigarette smoke was collected on a Cambridge filter pad and extracted in 20 mL of 2-propanol (MilliporeSigma, Burlington, MA, USA, OmniSolv grade, CAS #67-63-0) containing 0.5 mL/L of n-heptadecane (Alfa-Aesar, Ward Hill, MA, USA, 99%, CAS #629-78-7) and 5 mL/L of ethanol (Sigma-Aldrich, St. Louis, MO, USA, 200 proof anhydrous, CAS #64-17-5) as internal standards. An aliquot of the sample solution was analyzed with an Agilent (Santa Clara, CA, USA) 6890N gas chromatograph equipped with a flame ionization detector (FID) and a thermal conductivity detector. The nicotine was analyzed on the FID channel using a custom stainless steel Supelco (Bellefonte, PA, USA) column measuring 6 ft × 1/8 in × 2.1 mm with 7% Carbowax, 3% OS-138, 2% KOH, 80/100 Chromosorb WHP packing. The water was analyzed on the TCD channel using a custom stainless steel Supelco column measuring 10 ft × 1/8 in × 2.1 mm with 80/100 Porapak QS packing. The "tar" (nicotine free dry particulate matter -NFDPM) was calculated by subtracting resulting nicotine and water from the TPM. The limit of detection under ISO 3308 for nicotine and water was 1.2 µg/cig and 80 µg/cig respectively while the limit of detection under ISO 10315 for nicotine and water was 2.0 µg/cig and 133 µg/cig respectively.
Determination of carbon monoxide by non-dispersive infrared absorption
The vapor phase of the smoke was collected in gas sampling bags attached to the smoking machine. A Cerulean non-dispersive infrared absorption detector (NDIR) was used to measure the CO concentration in the vapor phase in percent by volume (% vol). The NDIR detector was calibrated using specialty gases from ARC3 (Richmond, VA) with certified concentrations of 1%, 3%, and 6% (vol) CO in nitrogen. Using the number of cigarettes, the cigarette puff count, the puff volume, and ambient temperature and humidity conditions, the % CO was converted to mg/cig.
Determination of nicotine in tobacco filler by GC-FID
5 mL of 2N sodium hydroxide (Fluka, Morristown, NJ, USA, CAS #1310-73-2) was added to the tobacco (1.00 g ± 0.1 g) and allowed to stand for 15 min. 50 mL of methyl tert-butyl ether (Macron, Allentown, PA, CAS #1634-04-4) containing 0.4 mg/mL of the internal standard quinoline (Alpha-Aesar, 98%, CAS #91-22-5) was then added and the sample was placed on an orbital shaker for 2 hours at 200 RPM. An aliquot of the organic layer was analyzed with an Agilent 7890 gas chromatograph equipped with a flame ionization detector. Analyte separation was achieved using an Agilent J&W HP-5 30 m × 320 µm × 0.25 µm column. The limit of detection for this method was approximately 150 µg/g tobacco. 
Determination of nicotine in tobacco filler by GC/MS
4 mL of 5N NaOH (Fisher Chemical, Fair Lawn, NJ, USA) was added to the tobacco (0.5 g ± 0.1 g) into a 50 mL conical tube and allowed to stand for 30 min. 40 mL of methanol (Fisher, distilled in glass) containing 50 µg/mL of the internal standard quinoline (Alfa-Aesar P/N 43225) was added to the conical tube along with 2 grinding stones (US Stoneware, East Palestine, OH, USA, P/N Brun050-090). The sample was then placed on the 2010 Geno-grinder (Spex, Metuchen, NJ, USA) for 30 min at 1000 RPM. Samples were removed from the grinder and placed into a centrifuge (Sorvall Legend XT by Thermo Fisher Scientific, Waltham, MA, USA) for 10 min at 3000 RPM. An aliquot of the methanol extract was analyzed with an Agilent 7890 GC equipped with a 5975C MSD. Analyte separation was achieved on an Agilent Cam column (30 m × 0.250 mm × 0.25 µm). The limit of detection for nicotine was 0.88 µg/g tobacco.
RESULTS
Cigarettes were analyzed for the amount of nicotine in the tobacco filler and also for the amount of nicotine in the smoke. "Tar" and carbon monoxide in smoke were also analyzed. The results of the analyses are presented in Table 3 . Tobacco filler has varying amounts of water dependent on how the product was manufactured and on the humectants used. Nicotine in the tobacco filler is presented as it was measured ("as is" basis) and then corrected to a dry weight basis. As expected, there was no difference in the nicotine content or yield between VLN™ Kings and VLN™ Menthol Kings since the only difference between the two products is addition of a menthol solution to the filter. On an "as is" basis the average nicotine in the tobacco filler for the top 100 brand styles in the U.S. was 17.2 mg nicotine/g tobacco filler. The amount of nicotine in VLN™ was 0.41 mg/g tobacco on an "as is" basis. When the results were corrected for variations in the water content, the top 100 brand styles averaged 19.4 mg nicotine/g tobacco filler dry weight (range 14.7-33.2). VLN™ cigarettes averaged 0.47 mg of nicotine /g tobacco filler. Figure 1 shows the dramatic differences between VLN™ products and the top 100 brand styles sold in the U.S. A more relevant comparison is on a cigarette basis. The weight of tobacco varies between commercial cigarettes. On a per-cigarette basis the average nicotine in the tobacco filler for the top 100 brand styles in the U.S. was 12.0 mg nicotine/cig (range 8.2-24.1). The amount of nicotine in VLN™ was 0.27 mg/cig. Figure 2 illustrates the differences between VLN™ products and the top 100 brand styles sold in the U.S. on a per-cigarette basis. The smoke from the cigarettes was also analyzed under ISO smoking conditions to see if design differences might affect the theoretical amount of nicotine delivered to the smoker. The average nicotine yield was 0.903 mg/cig (range: 0.38-1.82) for the top 100 brand styles. VLN™ cigarettes yielded 0.03 mg nicotine/cig under ISO smoking conditions. Figure 3 graphically presents the differences between VLN™ cigarettes and the top brand styles. On a percigarette basis VLN™ cigarettes contained 0.27 mg of nicotine in the tobacco and yielded 0.03 mg of nicotine in the smoke, a conversion efficiency of 11.1%. The commercial cigarettes contained on average 12 mg of nicotine per cigarette and yielded 0.903 mg of nicotine in smoke, a conversion efficiency of 7.5%. These differences in efficiency are not unexpected since yield is dependent on the amount of tobacco, the type of filter, and the amount of ventilation. VLN™ cigarettes contain about 650 mg of tobacco which is consistent with the amount of tobacco normally used in conventional king size cigarettes. Some of the marketed cigarettes in the top 100 list were 100's 2 which generally contain more tobacco and generally have slightly higher "tar" yields on a per-cigarette basis. Most commercial filter cigarettes in the U.S. use a single cellulose acetate filter with or without added carbon. The filter used in VLN™ was a dual filter made up of a cellulose acetate segment on the mouth end and a crepe paper filter on the tobacco end. This different filter design and different degrees of ventilation (ventilation was not measured in this study for the commercial cigarettes) may account for some of the differences in the nicotine yield. "Tar" and carbon monoxide were also measured in the cigarette smoke. The average "tar" yield in smoke for the top brand styles was 11.96 mg/cig (range 4.5-18.0). The average "tar" yield for VLN™ was 7 mg/cig. "Tar" yield is dependent on the amount of tobacco, the type of filter, and the amount of ventilation which may be different between VLN™ cigarettes and the top brands. The average CO yield for the top brands was 12.4 mg/cig (range 6.3-18.3). The average CO yield for VLN™ was 11.2 mg/cig. The amount of CO in smoke is determined mostly by the amount of ventilation in the tipping paper.
3 VLN™ uses a tipping paper with about 13% ventilation. The amount of ventilation in commercial cigarettes can range from 0 to 70% (18) .
DISCUSSION
VLN™ cigarettes are substantially lower in nicotine than any other cigarettes currently sold to consumers in the United States -whether measured on a cigarette, tobacco dry weight, or cigarette smoke yield basis. VLN™ cigarettes contain a target level of 0.5 mg of nicotine/g of tobacco filler (dry weight). The actual measured amount was 0.47 mg of nicotine/g of tobacco. Analysis of the top 100 leading cigarette brands in the U.S. showed that, on average, these cigarettes contained 19.4 mg of nicotine/g of tobacco on a dry weight basis. Accordingly, the nicotine content of VLN™ cigarette tobacco is 97.6% lower than the average nicotine content of the tobacco filler in the top 100 leading brands. When compared to the lowest nicotine content product of any of the top 100 leading US brands, "L&M 100", the nicotine content of VLN™ is 96% lower. When compared on a cigarette basis, the top 100 brands average 12.0 mg of nicotine and VLN™ averages 0.27 mg. Therefore, without exception, VLN™ cigarettes contain at least 95% less nicotine than the top 100 brands in the U.S.. Similarly, the amount of nicotine in smoke (yield) for VLN™ cigarettes is 0.03 mg/cig, which is also 97% lower than the top 100 cigarette brand style's nicotine smoke yields (0.903 mg/cig). Because of the unique technology used to reduce nicotine and the absence of the technology in any other commercial cigarette on the market, it is believed that the nicotine level in VLN™ is reduced by at least 95% when compared to all other cigarettes available in the U.S. marketplace irrespective of the comparison basis. Clinical studies indicate that use of VLN™ cigarettes can lead to substantial reductions in nicotine exposure (19) (20) (21) (22) (23) as a result of the lower nicotine delivery and also due to an overall reduction in cigarettes consumed per day (20, (23) (24) (25) (26) (27) . In the longest (20 weeks) and largest (1,250 subjects with no intention to quit) study to date on SPECTRUM®/VLN™ cigarettes, HATSUKAMI et al. observed more than a 50%-reduction in cigarettes per day (28) . The "gold standard" for measuring reduced nicotine exposure is the amount of total nicotine equivalents (TNE) in the urine. HATSUKAMI et al. observed a 57% reduction in TNE in the 20-week study with SPECTRUM®/VLN™ cigarettes. There is clear evidence that consumption of cigarettes that have very low levels of nicotine in the tobacco will result in reductions in the nicotine in the smoke and the smoker will be exposed to significantly lower levels of nicotine as indicated by the total nicotine equivalents in the urine. This is due to reduced nicotine intake and cigarette consumption over the duration of use. KAMENS et al. (29) compared the pharmacokinetic profile of SPECTRUM®/VLN™ cigarettes to usual brand after a single use in twelve daily cigarette smokers. Nicotine area under the curve was reduced by 95%. In most clinical studies with VLN™ there is a tendency for subjects to "cheat" and use non-study cigarettes (30) (31) (32) . This probably accounts for the only 57% reduction in TNE observed by HATSUKAMI et al. after 20 weeks of use compared to the 95% reduction in nicotine plasma levels after single use under confined circumstances. There is very little nicotine in VLN™ cigarettes and compensation has not been observed after long term use (19, 20, 21, 23, 28) . Premarket Tobacco Applications (PMTA) and Modified Risk Tobacco Applications (MRTPA) were submitted to the United States Food and Drug Administration for VLN™ cigarettes in December of 2018. Section 911(h)(2)(B) of the Tobacco Control Act states that the Secretary may require that the percent (or fraction) of change and identity of the reference tobacco product and a quantitative comparison of the amount of the substance claimed to be reduced shall be stated in immediate proximity to the most prominent claim. The principal reduced exposure claim for the VLN™ King and VLN™ Menthol King products will be "95% Less Nicotine". This claim is based on the nicotine content of the filler in the cigarette irrespective of the basis of comparison (per g of tobacco filler, per g of tobacco filler calculated on a dry weight basis, or per cigarette). The tobacco filler target nicotine level is 0.5 mg nicotine/g of tobacco filler (dry weight). The top 100 brand styles in the U.S. were identified and analyzed. These results demonstrated that VLN™ cigarettes had reduced nicotine levels of 95% less in the tobacco filler and smoke compared to the top 100 brands representing over 80% of all cigarettes sold in the U.S. Because of the unique technology used to reduce nicotine and the absence of the technology in any other cigarette on the market, it is believed that the nicotine level in VLN™ is 2 King size cigarettes are generally considered to be about 85 mm long and 100's are about 100 mm long. While these terms are used as general indicators of the length of the cigarettes, manufacturers may make cigarettes with slightly different lengths that are sold as belonging to either the category "Kings" or "100's".
3
The focus of this research was the nicotine content and nicotine yield of the cigarettes. Ventilation was not measured. reduced by at least 95% when compared to all other cigarettes in the marketplace and a comparator statement such as "leading brands", "usual brand", "typical brands", or "top three brands" is not required. Analysis of the smoke yield of VLN™ cigarettes also demonstrated that the amount of nicotine in smoke was reduced at least 95% also.
